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Recent data have provided molecular evidence of high levels of endoplasmic reticulum
stress in non-laboured placentas from cases of early-onset pre-eclampsia. Endoplasmic
reticulum stress is intricately linked to oxidative stress, and the two often share the same
aetiology. In the case of pre-eclampsia this is likely to be placental malperfusion, secondary
to deﬁcient conversion of the spiral arteries. Endoplasmic reticulum stress activates a num-
ber of signalling pathways aimed at restoring homeostasis, but if these attempts fail then
the apoptotic machinery may be activated. The potential consequences for placental devel-
opment and function are numerous and diverse. Inhibition of protein synthesis results in
lower levels of many kinases, growth factors and regulatory proteins involved in cell cycle
control, and experiments in vitro reveal that endoplasmic reticulum stress slows cell pro-
liferation. Chronic, low levels of stress during the second and third trimesters may there-
fore result in a growth restricted phenotype. Higher levels of endoplasmic reticulum
stress lead to activation of pro-inﬂammatory pathways, a feature of pre-eclampsia that
may contribute to maternal endothelial cell activation. These ﬁndings emphasise the com-
plexity of cellular responses to stress, and the need to approach these in a holistic fashion
when considering therapeutic interventions.
 2010 International Society for the Study of Hypertension in Pregnancy. Published by
Elsevier B.V. All rights reserved.1. Introduction
Placental dysfunction has long been implicated in the
pathophysiology of pre-eclampsia. The evidence is particu-
larly compelling in the early-onset form of the syndrome, to
the point that this has been referred to as ‘placental pre-
eclampsia’ [1]. In the classic two-stage model of the syn-
drome, deﬁcient spiral arterial conversion is thought to lead
to placental oxidative stress through malperfusion, which
induces the placenta to release factors into the maternal
circulation that cause endothelial cell activation [2,3].
There is a wealth of data indicating that placental oxidativel Society for the Study of H
Physiology, Develop-
e CB2 3EG, UK. Tel.:stress occurs in the early-onset form of the syndrome [4,5],
and experiments conducted on term villous explants
in vitro have conﬁrmed that oxidative stress is a sufﬁcient
stimulus for the release of an array of cytokines and pro-
inﬂammatory factors from the trophoblast [6]. The explant
model system has enabled the intermediary signalling
pathways activated to be identiﬁed [7], and the relevance
of these to the in vivo situation is conﬁrmed by the fact that
the same changes are seen following labour, when placen-
tal oxidative stress is induced through ischaemia–reperfu-
sion secondary to uterine contractions [8]. Oxidative
stress can cause widespread disruption of cell function
however, and rarely occurs in isolation to other cell stress
responses. Over the last decade, close links have been iden-
tiﬁed between oxidative stress and endoplasmic reticulum
(ER) stress, with each being able to induce the other [9–11].
The ER is most commonly recognised for its role
in the post-translational modiﬁcation of proteins, butypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.
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co-ordinator of diverse signalling pathways regulating cell
metabolism, proliferation and death. This role is perhaps
not surprising given that protein synthesis is central to cel-
lular integrity and function, and is a heavily energy depen-
dent process requiring an adequate supply of nutrients and
oxygen. Disturbances of ER function lead to a state known
as ER stress, and activate a series of evolutionarily con-
served signalling pathways collectively referred to as the
Unfolded Protein Response (UPR). Initially, the UPR aims
to restore ER homeostasis, but if these attempts fail then
the apoptotic cascade is activated. These pathways are
now recognised as playing a central role in the pathophys-
iology of chronic diseases, such as neurodegenerative dis-
eases and diabetes [12]. Here, we consider evidence that
they also contribute to the placental pathology in cases
of early-onset pre-eclampsia.2. The endoplasmic reticulum
The ER consists of a series of interconnecting ﬂattened
membranous sacs with an intraluminal space of 20–
30 nm located in the perinuclear region of a cell, being
continuous with the outer membrane of the nucleus. It
is responsible for the synthesis and post-translational
folding and assembly of all secretory and membrane-
bound proteins, including hormones, growth factors and
receptors. The amount of ER within a cell therefore differs
according to the cell’s function, being large in cells with a
high secretory activity, such as beta pancreatic cells and
the syncytiotrophoblast. Proteins destined for the ER are
identiﬁed by a short leading sequence of hydrophobic
amino acids at the N-terminus end, which is recognised
by the signal recognition particle, a ribonucleoprotein
within the cytosol. Synthesis of all proteins starts on a
ribosome free within the cytosol, but when the ER signal
sequence is recognised by the signal recognition particle
the latter binds the ribosome complex to a receptor on
the outer surface of the ER membrane. This arrangement
creates the characteristic beaded appearance at the ultra-
structural level referred to as rough endoplasmic reticu-
lum, and enables the nascent polypeptide chain to be
threaded through a translocation channel, the translocon,
into the ER lumen. Once within the lumen, the signal
sequence is cleaved, and chaperone proteins bind to the
polypeptide chain to prevent premature and inappropri-
ate folding. Glucose-regulated protein GRP78/BiP, a mem-
ber of the HSP70 family, binds to hydrophobic amino acid
groups of secretory proteins, and facilitates folding
through the hydrolysis of ATP by an ATPase domain.
Calnexin and calreticulin are speciﬁcally involved in the
folding of glycoproteins, binding to monoglucosylated
N-linked glycans [13].
The ER also acts as a major intracellular store of
calcium, and the concentration within the lumen is often
several thousand-fold higher than in the cytosol, reaching
millimolar levels [14]. This gradient is maintained by the
activity of Ca2+-ATPases within the ER membrane, and is
considered necessary for functioning of the protein folding
machinery and chaperone proteins [15].3. Protein folding and assembly
Correct folding into the secondary and tertiary confor-
mation, and assembly into multimeric complexes, is essen-
tial for the functional competence of many proteins. For
the extracellular proteins passing through the ER this most
commonly involves the formation of covalent disulﬁde
bonds between cysteine side chains, either within different
parts of a polypeptide chain or between two such chains.
For example, the alpha sub-unit of human chorionic gona-
dotropin contains ﬁve disulphide bonds, while the beta
sub-unit contains six [16]. Formation of disulﬁde bonds is
an oxidative event, and consequently the ER is a site of sig-
niﬁcant production of reactive oxygen species (ROS) within
the cell [17]. During the formation of a disulﬁde bond elec-
trons are ﬁrst removed from the cysteine thiol groups by
the enzyme protein disulﬁde isomerase, PDI, and are trans-
ferred to molecular oxygen by the enzyme ER oxidoreduc-
tion, ERO1, using FAD as an intermediate. Because of the
kinetics, full reduction of oxygen may not occur, in which
case ROS intermediates such as hydrogen peroxide will
be produced [17]. Consequently, the ratio of reduced to
oxidised glutathione, the principal redox buffer within
the ER lumen, is approximately 3:1 compared to that of
approximately 100:1 in the cytosol [18].
If the protein load exceeds the capacity of the folding
machinery then unfolded or misfolded proteins will accu-
mulate within the ER lumen. This is a potentially danger-
ous situation for a cell as it may lead to loss of function
of membrane receptor proteins or secreted hormones.
Equally, considerable energy may be spent attempting to
refold the proteins, resulting in depletion of reserves and
excessive generation of ROS. In order to guard against
these eventualities, cells have evolved the UPR [19,20].
This aims to restore homeostasis within the ER lumen
by; (i) reducing the burden on the folding machinery
through limiting the number of new polypeptide chains
entering the ER lumen, (ii) increasing the capacity of the
machinery by synthesising more ER, (iii) generating more
chaperone proteins, and (iv) removing accumulated mis-
folded proteins through stimulation of the ER-associated
proteosomal degradation pathway (ERAD). If homeostasis
cannot be re-established then the apoptotic cascade is acti-
vated so that the cell is removed in a co-ordinated manner.4. The unfolded protein response
The UPR comprises three conserved signalling cascades.
The sensors are ER transmembrane proteins, each of which
has a luminal domain projecting into the lumen and a cyto-
plasmic domain that transmits the signal downstream. Un-
der normal conditions the sensors are held in an inactive
state by the binding of GRP78, and activation occurs when
this is titrated away by competitive binding to accumu-
lated proteins within the lumen.
PERK (double-stranded RNA-dependent protein kinase
(PKR)-like ER kinase), is a Ser/Thr protein kinase. Upon re-
lease from GRP78 it dimerises and undergoes autophos-
phorylation, activating the kinase domain. The principal
target of p-PERK is eukaryotic translation-initiation factor
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binding of tRNAs to the ribosomal sub-unit. Phosphoryla-
tion of eIF2a inhibits its activity, therefore rapidly blocking
further entry of nascent proteins into the ER lumen and
reducing the protein load within the lumen. Paradoxically,
although there is a global reduction in protein synthesis,
the translation of selected mRNAs is favoured under these
conditions. mRNAs containing either small upstream open
reading frames or internal ribosome entry sites are able to
by-pass this block, and so an increase in their encoded pro-
teins is observed. A key example is activating transcription
factor-4, ATF4, which translocates to the nucleus and acti-
vates GADD34 (growth-arrest DNA damage gene 34) and
CHOP, amongst others. GADD34 provides a negative feed-
back on protein synthesis inhibition by dephosphorylating
p-eIF2a, allowing translation to resume if ER homeostasis
has been restored.
ATF6 (activating transcription factor 6) translocates to
the Golgi following release from GRP78, where it is cleaved
into an active form that migrates to the nucleus and regu-
lates transcription of GRP78, CHOP and Xbp1. In this way
synthesis of the ER chaperone proteins is increased under
low-grade stimulus, or apoptosis is induced under more
severe stress.
Ire1 (inositol-requiring transmembrane linase/endonu-
clease 1) dimerises after release from GRP78, and contains
both an endoribonuclease domain and a Ser/Thr kinase do-
main. The former splices Xbp1 mRNA, generating a func-
tional transcription factor that binds to the UPR elements
of many genes involved in ER function. It notably up-
regulates lipid biosynthesis, forming more ER cisternae,
genes involved in the protein folding machinery, and
enzymes of the ERAD pathway promoting clearance of
misfolded proteins. Importantly, in the context of pre-
eclampsia, Ire1 can also activate pro-inﬂammatory path-
ways through its kinase domain. Acting through TRAF2
(tumour necrosis factor-receptor-associated factor 2) and
ASK1 (apoptosis signal-regulating-kinase 1) it stimulates
the p38 MAPK, JNK and NFB pathways, leading to the re-
lease of inﬂammatory cytokines.
If the UPR fails to overcome the accumulation of mis-
folded proteins, a ﬁnal signalling pathway is triggered to
eliminate the cell by activation of cleavage of caspase 4
(caspase-12 in mouse), located in the ER membrane [21].
This ER-speciﬁc caspase is able in turn to activate the
downstream effector caspase 9 directly, independent from
the Apaf1 and mitochondrial cytochrome c pathway [22].
In addition, CHOP induced by PERK and ATF6 can sensitize
cells to apoptosis, through suppression of the anti-apopto-
tic factor B cell lymphoma-2 (Bcl-2) gene expression and
upregulation of Bim, a proapoptotic BH3-only member of
the Bcl-2 family [23,24].5. Evidence of graded activation of the UPR in
trophoblast-like cells
The UPR thus provides an integrated response to the
accumulation of unfolded or misfolded proteins within
the ER lumen, with synergy and some overlap in function
between the signalling pathways. Teleologically, it mightbe expected that the response would act in a graded fash-
ion, with initial attempts to restore ER homeostasis being
followed later by activation of the apoptotic cascade if they
fail. Application of increasing concentrations of tunicamy-
cin, a blocker of glycosylation and hence a powerful indu-
cer of ER stress, to JEG-3 choriocarcinoma cells has shown
that this is indeed the case [25]. Phosphorylation of eIF2a
is seen at the lowest doses, followed by upregulation of
the chaperone proteins GRP78 and 94, and splicing of
Xbp1mRNA as the concentration rises. An increase in CHOP
is seen at the higher concentrations of tunicamycin, and is
associated with elevated rates of apoptosis. Equally, activa-
tion of the different pathways can be separated temporally.
Application of a non-lethal dose of tunicamycin to JEG-3
cells results in rapid phosphorylation of eIF2a, and a
slower increase in the chaperone proteins. No increase in
CHOP is observed with this low-grade stimulus. There is
therefore considerable evidence of a graded response from
this model system, although how this is regulated at the
molecular level is currently unknown.6. Evidence of placental ER stress in pregnancies
complicated by early-onset pre-eclampsia
Dilation of the ER cisternae within the syncytiotropho-
blast indicative of a loss of ER homeostasis has been previ-
ously reported in cases of pre-eclampsia [26], although its
physiological signiﬁcance in terms of the UPR was not
appreciated at the time (Fig. 1). Similar dilation has also
been associated with anoxia in placental samples that are
not ﬁxed immediately after delivery, or are malperfused
in vitro [27].
We have recently provided the ﬁrst molecular evidence
of activation of the UPR in placentas from cases of normo-
tensive intrauterine growth retardation (IUGR) and from
IUGR associated with early-onset pre-eclampsia (IUGR+PE)
[25]. In both sets of placentas we observed phosphoryla-
tion of eIF2a, which was absent in control placentas
delivered at term by caesarean section. The degree of phos-
phorylation was greater in the IUGR+PE cases, suggesting a
higher level of ER stimulation. Commensurate with this
hypothesis, we observed increased levels of CHOP in the
IUGR+PE cases, but not in IUGR alone, and immunohisto-
chemistry localised this principally to the syncytiotropho-
blast and the endothelial cells of the fetal capillaries. There
was also a rise in GRP94 in IUGR+PE, but not in IUGR alone.
No change in GRP78 was observed in either pathology,
and interestingly was also not found under oxygen-glucose
deprivation in JEG-3 cells where there was an increase of
P-eIF2a and CHOP and cleavage of Xbp-1 mRNA [28].
Extensive splicing of Xbp1 mRNA was seen in both IUGR
and IUGR+PE placentas, and was not signiﬁcantly different
between the two conditions.7. Signiﬁcance of ER stress in the pathophysiology of
pre-eclampsia
Given both the morphological and molecular evidence
of ER stress in early-onset pre-eclamptic placentas, what
Fig. 1. Electron micrographs of the syncytiotrophoblast in (A) a normal placenta, and (B) a case of pre-eclampsia. Both placentas were delivered at term
following caesarean section. In the normal placenta the cisternae of endoplasmic reticulum display only minimal dilation (arrow), whereas in the pre-
eclamptic placenta they are widely dilated (asterisk) and ﬁlled with an amorphous proteinaceous precipitate. Scale bars = 1 lm.
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disorder?
ER stress can be induced by many stimuli, and the pre-
cise cause in pre-eclampsia is not known. However, an
ischaemia–reperfusion-type injury is a strong possibility
given the associated spiral arterial pathology. Early-onset
pre-eclampsia, along with IUGR, has long been associated
with deﬁcient conversion of the endometrial spiral arteries
secondary to poor trophoblast invasion. Conversion
normally extends from the placental interface as far as
the inner third of the myometrium, and is associated with
the loss of smooth muscle and the elastic lamina from the
vessel walls. Exact quantiﬁcation of the degree of conver-
sion is difﬁcult, given the small size and number of the
samples available for study. However, there is general
agreement between studies that the myometrial segments
of the arteries are more adversely affected in pathological
pregnancies than the decidual segments, and that the def-
icit is greater in cases associated with pre-eclampsia than
IUGR alone [29–33]. The portion of the artery just below
the endometrial/myometrial boundary represents a spec-
ialised highly contractile segment [34], that is thought to
prevent excessive blood loss at the time of menstruation.
In view of this, we recently proposed that retention of this
segment in cases of pre-eclampsia predisposes to sponta-
neous vasoconstriction, and hence to an ischaemia–
reperfusion-type injury [35,36]. Cerebral ischaemia is a
powerful inducer of the UPR [37], and subjecting JEG-3
cells to hypoxia-reoxygenation causes phosphorylation of
eIF2a [25]. This situation may be made worse by changes
in posture, which in the bipedal human can inﬂuence uter-
ine blood ﬂow [38], or heightened uterine contractility, as
maternal placental blood is reduced during a contraction
[39].
The intervening steps in vivo are unclear at present, but
various possibilities exist. Episodes of ischaemia will de-
plete intracellular concentrations of glucose, which may
restrict normal glycosylation within the ER, activating the
UPR. Alternatively, ischaemia will reduce intracellular lev-
els of ATP, compromising the functioning of the GRP chap-
erone proteins, and possibly also the Ca2+-ATPase ionic
pumps within the ER membrane. Ischaemia may also have
a more direct effect on calcium release from the ER by
altering the redox balance within the cell, affecting thiol
groups on the calcium channel proteins [40]. Calciumimbalance may further result from competitive binding
of GRP78 to misfolded proteins, for under normal condi-
tions GRP78 serves to plug unoccupied translocons, pre-
venting leakage. Loss of calcium from the ER lumen will
compound the situation by compromising the protein fold-
ing machinery, and by activating calcium dependent sig-
nalling pathways within the cytsol. Ultimately, these
could lead to opening of the mitochondrial membrane
transition pore, with subsequent loss of mitochondrial
function and generation of ROS. We have previously dem-
onstrated that hypoxia-reoxygenation of villous explants
leads to opening of the pore, and activation of apoptosis
within the syncytiotrophoblast [41]. Further work is re-
quired to tease apart these various possibilities, but the
complex interactions between oxidative and ER stress
mean that once one is initiated the other is likely to follow
soon after through feed-forward mechanisms.
In many instances pathological activation of the UPR is
a one-off event, following for example stroke or myocardial
infarction. As mentioned earlier, phosphorylation of eIF2a
and inhibition of protein synthesis are usually transient
events, for activation of ATF4 leads to upregulation of the
phosphatase GADD34. However, the precipitating vascular
insult to the placenta in pre-eclampsia is likely to be of a
lower grade than that in stroke, and also of a repetitive nat-
ure. To mimic this in vitro we have exposed JEG-3 cells to
repetitive cycles of hypoxia-reoxygenation and observed
sustained phosphorylation of eIF2a and activation of the
UPR. We predict therefore that the ER stress is of a chronic
nature, dating most likely from the time of onset of the
maternal circulation at the end of the ﬁrst trimester.
The consequences for placental function are manifold,
and are just beginning to be explored [42]. In the absence
of more extensive data, four aspects will be considered
here; the impact on placental development, the impact
on placental function, the impact on placental apoptosis,
and the impact on inﬂammation.
8. Impact on placental development
The protein synthesis inhibition seen as a result of the
phosphorylation of eIF2a has a number of consequences
for placental development, since a range of kinases and
other regulatory proteins are affected. We have observed
that levels of all three isoforms of AKT are reduced at the
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placentas, suggesting that translation is suppressed [25].
A reduced level of total AKT is also observed in JEG-3 cells
following exposure to hypoxia-reoxygenation, glucose
deprivation or tunicamycin, and a pulsed radiolabelled
methionine experiment conﬁrmed reduced protein syn-
thesis [28]. AKT plays a central role in regulating cell pro-
liferation, and this loss of activity is likely to have a severe
detrimental effect on placental development. Knock-out of
Akt1 in the mouse results in placental and fetal IUGR, and
although there may be compensatory increases in Akt2
and Akt3, there is a close linear correlation between the
level of phospho-Akt and placental weight [25,43].
Another protein severely affected by the UPR is cyclin
D1, and levels have been reported to be severely reduced
following ischaemia in the brain [44]. We found cyclin
D1 to be depleted in IUGR and IUGR+PE placentas [25].
These two effects on AKT and cyclin D1 are likely to
have a major impact on the rate of proliferation of placen-
tal cells. This rate is impossible to estimate longitudinally
during pregnancy, but counts of cytotrophoblast cells
immunopositive for proliferation markers at delivery re-
veal a lower frequency in IUGR placentas than in controls
[45]. Equally, exposure of JEG-3 cells to low-dose tunica-
mycin or repetitive cycles of hypoxia-reoxygenation slows
their proliferation whilst increasing phosphorylation of
eIF2a [25]. Although there can be no direct proof that these
changes in AKT and cyclin D1 are causal, they are consis-
tent with the smaller placental phenotype observed in
IUGR, and to a greater extent in IUGR+PE [46].
In addition, the syncytiotrophoblast secretes a wide ar-
ray of growth factors, such a vascular endothelial growth
factor and members of the insulin-like growth factor fam-
ily, that may act in an autocrine or paracrine fashion.
Reduced synthesis or loss of function through malfolding
could adversely affect placental development, for knock-
out of the trophoblast speciﬁc P0 promoter of Igf2 in the
mouse results in placental and fetal IUGR [47].
9. Impact on placental function
The placenta is a major endocrine organ, secreting both
peptide and steroid hormones that have a profound effect
on maternal physiology and metabolism. The peptide hor-
mones will be processed by the ER, and abnormal glycosyl-Fig. 2. Photomicrograph of placental villi immunolabelled for cleaved caspase 4
were delivered at term following caesarean section. The normal placenta d
syncytiotrophoblast covering the villi shows strong staining. Scale bars = 50 lmation or folding potentially impacts on their functional
capacity. For the syncytiotrophoblast candidate proteins
will include hormones such as human chorionic gonado-
tropin (hCG), placental lactogen (hPL), and placental
growth hormone. As mentioned earlier, hCG contains a
number of disulﬁde bonds, whereas hPL is secreted in large
quantities, up to 1 g per day, towards term. Both of these
hormones are thus vulnerable if normal ER function is per-
turbed, and so feto-maternal signalling and the capacity of
the placenta to inﬂuence maternal metabolism may be im-
paired. This may restrict the supply of glucose and free
fatty acids to the placenta.
The syncytiotrophoblast also expresses a wide array of
receptors that are involved in signalling and the transport
of nutrients. As these are membrane proteins they will be
processed by the ER, and so their conformation and activity
are potentially compromised during ER stress.10. Placental apoptosis
The release of apoptotic debris from the surface of the
syncytiotrophoblast is one of the many factors that has
been implicated in the second stage of the two-stagemodel
of pre-eclampsia [3]. Microvillous particles and placental
debris are highly irritant to endothelial cells invitro, leading
to activation and an inﬂammatory response [48]. Apoptosis
is increased in the trophoblast in early-onset pre-eclampsia
[49], and ER stress provides at least two potential pathways
to mediate this effect, activation of CHOP and of caspase 4.
We have observed evidence of both pathways in placentas
from early-onset pre-eclampsia, and localised them immu-
nohistochemically to the syncytiotrophoblast and the fetal
endothelial cells (Fig. 2). The former may be responsible for
increased shedding of placental debris from the syncytio-
trophoblast layer, whereas the latter may adversely impact
on the development and maintenance of the placental cap-
illary network.11. The association between ER stress and inﬂammation
A major advance in our understanding of the patho-
physiology of pre-eclampsia came with the recognition
that the syndrome is associated with a heightened mater-
nal inﬂammatory response [1,50]. Maternal circulatingfrom (A) a normal placenta and (B) a case of pre-eclampsia. Both placentas
isplays only minimal immunoreactivity, whereas in pre-eclampsia the
.
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eclampsia [51], and both these cytokines will cause
endothelial cell activation. Evidence of such activation is
provided by the ﬁnding of elevated levels of long pentraxin
3, a marker for inﬂammation involving a vascular bed, in
women with pre-eclampsia [52].
There are close links between ER stress and activation of
pro-inﬂammatory responses that may be mediated by var-
ious pathways [53]. Firstly, the kinase domain of Ire1 can
activate the p38 MAPK, JNK and NFjB pathways as previ-
ously described [54]. Secondly, protein synthesis inhibition
independently leads to activation of the NFjB pathway
since the half-life of the inhibitory sub-unit, IjB, is much
shorter than that of NFjB [55]. Thirdly, the ER produces
ROS as a by-product of protein folding, and this may be
accentuated during repeated attempts to refold misfolded
proteins. ROS can activate the NFjB pathway by stimulat-
ing phosphorylation of the IjB sub-unit, targeting it for
degradation.
Once activated, these inﬂammatory responses can form
feed-forward loops that build up into vicious cycles, for
TNF-a can induce the UPR in a ROS-dependent fashion
[10]. The source of the increased TNF-a in the maternal cir-
culation in pre-eclampsia is uncertain, however, although
the placenta is an obvious candidate. Oxidative stress
in vitro and in vivo leads to increased tissue concentrations
and secretion of the cytokine [7,8,56], and higher concen-
trations have been reported in pre-eclamptic placentas
compared to normal controls [57]. In contrast, a detailed
study of non-laboured pre-eclamptic placentas involving
sampling from eight independent sites revealed no differ-
ences at the mRNA or protein levels compared to controls
[58]. These authors concluded that there must be an alter-
native source of TNF-a, and speculated that this may be
activated maternal leucocytes or the endothelium itself.
Despite the widespread recognition that maternal
endothelial cell activation represents the second stage of
the syndrome, no morphological studies appear to have
been performed on peripheral endothelial cells from wo-
men with pre-eclampsia. It is therefore impossible to
determine at present whether ER stress occurs in these
cells, and whether this could contribute to the raised levels
of TNF-a. In contrast, there are several reports describing
dilation of the ER in the endothelial cells of the umbilical
vessels, indicating a loss of ER homeostasis [59,60]. If the
same pathology affects the endothelial cells in both circu-
lations during pre-eclampsia, as some authors suspect [61],
then it may be that ER stress is not restricted to the pla-
centa in pathological pregnancies. Further investigations
are required to explore this possibility.12. Conclusion
Endoplasmic reticulum stress represents one compo-
nent of a set of integrated cellular responses to stress.
There are complex interactions between it and oxidative
stress, and it is likely that in many pathologies the two will
co-exist. The extensive secretory activity of the syncytio-
trophoblast renders it vulnerable to ER stress, and molecu-
lar and morphological evidence conﬁrms high levels inplacentas from cases of early-onset pre-eclampsia. There
will be many consequences for placental development
and function, including a reduction in cell proliferation
leading to growth restriction, and activation of pro-inﬂam-
matory pathways. Potential therapeutic interventions for
pre-eclampsia must therefore be designed to address
trophoblastic stress in its entirety, rather than individual
stress response pathways.Acknowledgement
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